GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nutex Health Inc (NAS:NUTX) » Definitions » Beneish M-Score

Nutex Health (Nutex Health) Beneish M-Score : -3.02 (As of May. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nutex Health Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.02 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Nutex Health's Beneish M-Score or its related term are showing as below:

NUTX' s Beneish M-Score Range Over the Past 10 Years
Min: -3.02   Med: 0.95   Max: 4.92
Current: -3.02

During the past 5 years, the highest Beneish M-Score of Nutex Health was 4.92. The lowest was -3.02. And the median was 0.95.


Nutex Health Beneish M-Score Historical Data

The historical data trend for Nutex Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutex Health Beneish M-Score Chart

Nutex Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - - 4.92 -3.02

Nutex Health Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.92 27.87 -8.67 -2.56 -3.02

Competitive Comparison of Nutex Health's Beneish M-Score

For the Health Information Services subindustry, Nutex Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutex Health's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Nutex Health's Beneish M-Score falls into.



Nutex Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Nutex Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9532+0.528 * 0.5008+0.404 * 1.0669+0.892 * 1.1293+0.115 * 0.6948
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.5968+4.679 * -0.041128-0.327 * 1.131
=-3.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $62.8 Mil.
Revenue was 69.669 + 62.723 + 58.924 + 56.329 = $247.6 Mil.
Gross Profit was 13.213 + 7.066 + 9.647 + 4.848 = $34.8 Mil.
Total Current Assets was $90.8 Mil.
Total Assets was $398.2 Mil.
Property, Plant and Equipment(Net PPE) was $269.4 Mil.
Depreciation, Depletion and Amortization(DDA) was $17.6 Mil.
Selling, General, & Admin. Expense(SGA) was $36.1 Mil.
Total Current Liabilities was $58.3 Mil.
Long-Term Debt & Capital Lease Obligation was $255.7 Mil.
Net Income was -31.618 + -5.542 + -3.479 + -5.147 = $-45.8 Mil.
Non Operating Income was -30.55 + 0.01 + 0.124 + -0.247 = $-30.7 Mil.
Cash Flow from Operations was -1.776 + 1.968 + 0.012 + 1.052 = $1.3 Mil.
Total Receivables was $58.3 Mil.
Revenue was 53.724 + 28.395 + 58.048 + 79.127 = $219.3 Mil.
Gross Profit was -3.319 + -23.713 + 6.638 + 35.815 = $15.4 Mil.
Total Current Assets was $98.0 Mil.
Total Assets was $431.8 Mil.
Property, Plant and Equipment(Net PPE) was $295.2 Mil.
Depreciation, Depletion and Amortization(DDA) was $13.1 Mil.
Selling, General, & Admin. Expense(SGA) was $20.0 Mil.
Total Current Liabilities was $54.9 Mil.
Long-Term Debt & Capital Lease Obligation was $246.1 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(62.776 / 247.645) / (58.316 / 219.294)
=0.253492 / 0.265926
=0.9532

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(15.421 / 219.294) / (34.774 / 247.645)
=0.070321 / 0.140419
=0.5008

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (90.848 + 269.387) / 398.245) / (1 - (97.974 + 295.153) / 431.752)
=0.095444 / 0.089461
=1.0669

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=247.645 / 219.294
=1.1293

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(13.131 / (13.131 + 295.153)) / (17.592 / (17.592 + 269.387))
=0.042594 / 0.061301
=0.6948

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(36.066 / 247.645) / (20.001 / 219.294)
=0.145636 / 0.091206
=1.5968

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((255.681 + 58.313) / 398.245) / ((246.109 + 54.863) / 431.752)
=0.788444 / 0.697095
=1.131

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-45.786 - -30.663 - 1.256) / 398.245
=-0.041128

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Nutex Health has a M-score of -3.02 suggests that the company is unlikely to be a manipulator.


Nutex Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Nutex Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutex Health (Nutex Health) Business Description

Traded in Other Exchanges
N/A
Address
6030 S. Rice Ave, Suite C, Houston, TX, USA, 77081
Nutex Health Inc is healthcare services and operations company with 19 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Executives
Thomas T. Vo director, officer: Chairman, CEO 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Joshua Detillio officer: Chief Operating Officer 6030 S. RICE AVENUE, SUITE C, HOUSTON TX 77081
Jon Christian Bates officer: Chief Financial Officer 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Mitchell Creem director 700 NORTH BRAND BLVD., SUITE 450, GLENDALE CA 91203
Pamela W. Montgomery officer: Chief Legal Off. & Secretary 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Michael Lee Reed director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Cheryl Yvonne Grenas director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
John J Waters director 2165 TECHNOLOGY DRIVE, SCHENECTADY NY 12308
Danniel Stites director 3050 S. DOBSON ROAD, CHANDLER AZ 85248
Premier Macy Management Holdings, Llc 10 percent owner 2819 CYPRESS DRIVE, TEXARKANA TX 75503
Michael Bowen officer: Chief Financial Officer 501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701
Warren Hosseinion director C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Lawrence Schimmel officer: Chief Medical Information Off 5193 SW 75TH STREET, MIAMI FL 33143
Frederick Sternberg officer: President of subsidiary 10772 SANDY RUN RD, JUPTIER FL 33478
Micro Hospital Holding Llc 10 percent owner 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081